DanPET AB - Translational Biotech Company

Business areas:

Business areas:

• PET-ligands for science, development and diagnosis
• [3H]-ligands as biomarkers (in collaboration with Novandi Chemistry AB)
• Medicinal candidates in development

The future

The future

• DanPET is dressed for the future!

Mission:

Mission:

DanPET AB is committed to develop future biomarkers and medicines in areas where there is an unmet need - in collaboration with World Leading Partners

1/7
  • Home

  • About

  • News

  • Science

  • PET

  • Contact

  • More

    CONTACT US

    Dan Peters, Chief Executive Officer    

    E-mail:  info@danpet.eu